Deferred Tax Assets, Valuation Allowance of PDS Biotechnology Corp from 31 Dec 2014 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
PDS Biotechnology Corp quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2014 to 31 Dec 2024.
  • PDS Biotechnology Corp Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $64,655,056, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

PDS Biotechnology Corp Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $64,655,056 +$8,009,469 +14% 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q4 2023 $56,645,587 +$14,240,616 +34% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q4 2022 $42,404,971 +$11,888,653 +39% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q4 2021 $30,516,318 +$373,574 +1.2% 31 Dec 2021 10-K 28 Mar 2023 2022 FY
Q4 2020 $30,142,744 +$4,024,984 +15% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q4 2019 $26,117,760 +$20,869,377 +398% 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q4 2018 $5,248,383 -$45,036,624 -90% 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q4 2017 $50,285,007 +$10,512,712 +26% 31 Dec 2017 10-K 21 Feb 2019 2018 FY
Q4 2016 $39,772,295 +$18,098,088 +84% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q4 2015 $21,674,207 +$11,698,165 +117% 31 Dec 2015 10-K 02 Mar 2017 2016 FY
Q4 2014 $9,976,042 31 Dec 2014 10-K 08 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.